CCDC150 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.737400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.491600E-01
Normal-vs-Stage2
7.432000E-01
Normal-vs-Stage3
7.807400E-01
Normal-vs-Stage4
7.893000E-01
Stage1-vs-Stage2
8.765000E-01
Stage1-vs-Stage3
5.932200E-01
Stage1-vs-Stage4
8.872400E-01
Stage2-vs-Stage3
4.729600E-01
Stage2-vs-Stage4
9.551600E-01
Stage3-vs-Stage4
5.653200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.470000E-01
Normal-vs-AfricanAmerican
8.104000E-01
Normal-vs-Asian
6.324400E-01
Caucasian-vs-AfricanAmerican
8.443000E-01
Caucasian-vs-Asian
6.760800E-01
AfricanAmerican-vs-Asian
9.935600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.315000E-01
Normal-vs-Female
7.180000E-01
Male-vs-Female
8.279800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.576200E-01
Normal-vs-Age(41-60Yrs)
7.496200E-01
Normal-vs-Age(61-80Yrs)
6.375000E-01
Normal-vs-Age(81-100Yrs)
7.548600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.217000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.204600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.624800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.596000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.605800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.412800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.372000E-01
Normal-vs-Daily Drinker
6.859000E-01
Normal-vs-Weekly Drinker
5.482200E-01
Normal-vs-Occasional Drinker
6.662000E-01
Normal-vs-Social Drinker
6.966400E-01
Non Drinker-vs-Daily Drinker
5.794600E-01
Non Drinker-vs-Weekly Drinker
3.295600E-01
Non Drinker-vs-Occasional Drinker
5.563600E-01
Non Drinker-vs-Social Drinker
8.295800E-01
Daily Drinker-vs-Weekly Drinker
5.381000E-01
Daily Drinker-vs-Occasional Drinker
9.610000E-01
Daily Drinker-vs-Social Drinker
7.567400E-01
Weekly Drinker-vs-Occasional Drinker
5.837200E-01
Weekly Drinker-vs-Social Drinker
4.002800E-01
Occasional Drinker-vs-Social Drinker
7.194200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.355200E-01
Normal-vs-Grade 2
4.072200E-01
Normal-vs-Grade 3
3.224000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.211800E-01
Grade 1-vs-Grade 3
3.859000E-01
Grade 1-vs-Grade 4
4.355200E-01
Grade 2-vs-Grade 3
3.694800E-01
Grade 2-vs-Grade 4
4.072200E-01
Grade 3-vs-Grade 4
3.224000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.015400E-01
Normal-vs-NonDiabetic
5.933200E-01
Diabetic-vs-NonDiabetic
1.703760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.437400E-01
Normal-vs-NoPancreatitis
7.122000E-01
Pancreatitis-vs-NoPancreatitis
5.818400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
5.638000E-01
Normal-vs-N1
7.996800E-01
N0-vs-N1
1.986630E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.622000E-01
Normal-vs-TP53-NonMutant
5.853800E-01
TP53-Mutant-vs-TP53-NonMutant
5.556400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
